Watch Ticker

ImmunityBio, Inc. Common Stock

Go to ImmunityBio, Inc. Common Stock Website

$2.43

0.06 (2.53%)

Live

Previous Close

$2.41

Day Range

$2.33 - $2.45

Previous Day Range

$2.335 - $2.42

Market Cap

$2.1 billion USD

Day Vol.

6.5 million

Previous Day Vol.

7.0 million

Currency

USD

Primary Exchange

Nasdaq

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

Calidi Biotherapeutics is developing a groundbreaking genetic medicine platform using engineered viruses to precisely target and treat metastatic cancers, with promising preclinical data presented at AACR and ASCO conferences.

Related tickers: CLDI, VRTX, IBRX, CRSP, CTMX.

Read Full Article

N/A - HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

HCW Biologics reported financial results for Q2 2024, including a net loss of $15.3 million. The company reached a settlement agreement to resolve an arbitration case, and is pursuing a financing plan including an equity offering and out-licensing of non-core assets.

Related tickers: HCWB, IBRX.

Read Full Article

Trending Tickers

Please sign in to view